Table 2.
VARIABLES | MEDIAN (25TH-75TH PERCENTILE) | ||
---|---|---|---|
HEALTHY INDIVIDUALS | PATIENTS | aP VALUE | |
VWF:Ag (IU/dL) | |||
All blood group | 128 (94–163) | 242 (202–319) | <0.001 |
O blood group | 95 (83–126) | 259 (239–293) | <0.001 |
Non-O blood group | 148 (125–180) | 231 (194–340) | <0.001 |
VWFpp (U/dL) | |||
All blood group | 83 (74–98) | 230 (141–307) | <0.001 |
O blood group | 76 (62–93) | 187 (115–266) | <0.001 |
Non-O blood group | 83 (76–102) | 234 (141–317) | <0.001 |
VWFpp/VWF:Ag ratio | |||
All blood group | 0.7 (0.6–0.8) | 0.9 (0.6–1.2) | 0.006 |
O blood group | 0.8 (0.7–0.9) | 0.6 (0.4–1.0) | 0.531 |
Non-O blood group | 0.6 (0.5–0.8) | 0.9 (0.7–1.2) | <0.001 |
Note:
P < 0.05 is considered statistically significant.
Abbreviations: VWF, von Willebrand factor; VWF:Ag, von Willebrand factor antigen; VWFpp, von Willebrand factor propeptide.